High-dose therapy for Hodgkin's disease

This publication has 37 references indexed in Scilit:

• Peripheral blood stem cell versus autologous bone marrow transplantation for Hodgkin's disease: equivalent survival outcome in a single-centre matched-pair analysis
  British Journal of Haematology, 1999
• A Prognostic Score for Advanced Hodgkin's Disease
  New England Journal of Medicine, 1998
• Autotransplantation for relapsed or refractory Hodgkin’s disease: long-term follow-up and analysis of prognostic factors
  Bone Marrow Transplantation, 1998
• Treatment of patients with malignant lymphoma with Mini-BEAM reduces the yield of CD34+ peripheral blood stem cells
  Bone Marrow Transplantation, 1998
• Single and double autotransplants for relapsing/refractory Hodgkin’s disease: results of two consecutive trials
  Bone Marrow Transplantation, 1997
• Twelve Years Experience with High-Dose Therapy and Autologous Stem Cell Transplantation for High-Risk Hodgkin's Disease Patients in First Remission After MOPP/ABVD Chemotherapy
  Leukemia & Lymphoma, 1996
• Dose Intensification of Etoposide in the BEAM ABMT Protocol for Malignant Lymphoma
  Leukemia & Lymphoma, 1995
• Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial
  The Lancet, 1993
• Mini‐BEAM followed by BEAM and ABMT for very poor risk Hodgkin's disease
  British Journal of Haematology, 1992
• The potential value of very intensive therapy with autologous bone marrow rescue in the treatment of malignant lymphomas
  Hematological Oncology, 1987